Fundraising Fox
Find your path to Eric
203 people in our graph can introduce you to Eric.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Tom Cirrito to introduce you to Eric
You →Tom · together at Stemline Therapeutics (2012–2013) →Eric
Ask Jamie Chen to introduce you to Eric
You →Jamie · together at Jade Biosciences →Eric
Ask Sam Okafor to introduce you to Eric
You →Sam · 3 people · together at Silverback Therapeutics →Eric
Sign up to find every way you can get introduced to Eric
- Your email: the people you already email who know Eric
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Eric
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Venture Partner since 2024 with 25 years of biotech leadership experience. He was previously President and CEO of Chinook Therapeutics (acquired by Novartis) and Silverback Therapeutics, and COO at Seagen; he holds a law degree from UC Berkeley.
Experience
- Samsara BioCapitalVenture Partnercurrent2024 — present
- Jade BiosciencesChairman of the Board and Directorcurrent2024 — present
- Structure TherapeuticsDirectorcurrent2022 — present
- Janux TherapeuticsDirectorcurrent2024 — present
- Bluejay TherapeuticsLead Independent Director2024 — 2026
- ProfoundBioDirector and Advisor2023 — 2024
- Atara BiotherapeuticsDirector2015 — 2024
- Chinook Therapeutics, Inc.President & Chief Executive Officer2019 — 2023Vancouver, BC and Seattle, WA
- Adaptive Biotechnologies Corp.Director2016 — 2021
- Silverback TherapeuticsPresident & Chief Executive Officer2018Seattle, WA
- Stemline TherapeuticsDirector2012 — 2018
- SeagenChief Operating Officer2002 — 2017Greater Seattle Area
Skills & more
+7 more
CommercializationLifesciencesSecurities RegulationCorporate GovernanceMergersJoint VenturesIPOFrom Eric's professional profile.
Colleagues at Samsara BioCapital
Frequently asked questions
- Who is Eric Dobmeier?
- Venture Partner since 2024 with 25 years of biotech leadership experience. He was previously President and CEO of Chinook Therapeutics (acquired by Novartis) and Silverback Therapeutics, and COO at Seagen; he holds a law degree from UC Berkeley.
- Where does Eric Dobmeier work?
- Eric Dobmeier is Venture Partner at Samsara BioCapital.
- Where did Eric Dobmeier go to school?
- Eric Dobmeier studied at University of California, Berkeley - School of Law (J.D.); Princeton University (A.B.).
Founder mafias
University of California, Berkeley - School of Law mafia22
Also came through, then founded or led a company.
Samsara BioCapital mafia6
Also came through, then founded or led a company.
Adaptive Biotechnologies mafia5
Also came through, then founded or led a company.
Samsara Biocapital mafia4
Also came through, then founded or led a company.
Janux Therapeutics mafia3
Also came through, then founded or led a company.
Same school
Also attended University of California, Berkeley - School of Law130
+ 124 more
Also attended Princeton University1,027
+ 1,021 more
Shared employers
Also worked at Jade Biosciences1
Also worked at Structure Therapeutics2
Also worked at ProfoundBio3
Also worked at Adaptive Biotechnologies Corp.15
+ 9 more